Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

370 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT).
Bengala C, Guarneri V, Ledermann J, Rosti G, Wandt H, Lotz JP, Cure JH, Orlandini C, Ferrante P, Conte PF, Demirer T; EBMT Solid Tumor Working Party. Bengala C, et al. Among authors: ferrante p. Bone Marrow Transplant. 2005 Jul;36(1):25-31. doi: 10.1038/sj.bmt.1705007. Bone Marrow Transplant. 2005. PMID: 15908977
Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990-1999.
Pedrazzoli P, Ferrante P, Kulekci A, Schiavo R, De Giorgi U, Carminati O, Marangolo M, Demirer T, Siena S, Rosti G; European Group for Blood and Marrow Transplantation (EBMT), Solid Tumors Working Party. Pedrazzoli P, et al. Among authors: ferrante p. Bone Marrow Transplant. 2003 Sep;32(5):489-94. doi: 10.1038/sj.bmt.1704153. Bone Marrow Transplant. 2003. PMID: 12942095 Free article.
Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
Kröger N, Damon L, Zander AR, Wandt H, Derigs G, Ferrante P, Demirer T, Rosti G; Solid Tumor Working Party of the European Group for Blood and Marrow Transplantation; German Adjuvant Breast Cancer Study Group; University of California, San Francisco. Kröger N, et al. Among authors: ferrante p. Bone Marrow Transplant. 2003 Dec;32(12):1153-7. doi: 10.1038/sj.bmt.1704291. Bone Marrow Transplant. 2003. PMID: 14647269 Review.
Low incidence of secondary myelodysplasia and acute myeloid leukemia after high-dose chemotherapy as adjuvant therapy for breast cancer patients: a study by the Solid Tumors Working Party of the European Group for Blood and Marrow Transplantation.
Kröger N, Zander AR, Martinelli G, Ferrante P, Moraleda JM, Da Prada GA, Demirer T, Socie G, Rosti G; European Group for Blood and Marrow Transplantation. Kröger N, et al. Among authors: ferrante p. Ann Oncol. 2003 Apr;14(4):554-8. doi: 10.1093/annonc/mdg161. Ann Oncol. 2003. PMID: 12649100 Free article.
High-dose chemotherapy for solid tumors: results of the EBMT.
Rosti G, Ferrante P, Ledermann J, Leyvraz S, Ladenstein R, Koscileniak E, Crown J, Dazzi C, Cariello A, Marangolo M. Rosti G, et al. Among authors: ferrante p. Crit Rev Oncol Hematol. 2002 Feb;41(2):129-40. doi: 10.1016/s1040-8428(01)00150-0. Crit Rev Oncol Hematol. 2002. PMID: 11856589 Review.
The use of granulocyte colony-stimulating factors following peripheral blood progenitor cell rescue after high-dose chemotherapy for advanced breast cancer: a prospective study.
Dazzi C, Albertazzi L, Rosti G, Maestri A, Fiorentini G, Leoni M, Tienghi A, Turci D, Ferrante P, Vertogen B, Cariello A, Latino W, Zumaglini F, Marangolo M. Dazzi C, et al. Among authors: ferrante p. Tumori. 1997 Nov-Dec;83(6):900-3. doi: 10.1177/030089169708300605. Tumori. 1997. PMID: 9526580 Clinical Trial.
370 results